These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25244654)

  • 21. Bone morphogenetic protein-7 delays podocyte injury due to high glucose.
    De Petris L; Hruska KA; Chiechio S; Liapis H
    Nephrol Dial Transplant; 2007 Dec; 22(12):3442-50. PubMed ID: 17686813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of aryl hydrocarbon receptor mediates suppression of hypoxia-inducible factor-dependent erythropoietin expression by indoxyl sulfate.
    Asai H; Hirata J; Hirano A; Hirai K; Seki S; Watanabe-Akanuma M
    Am J Physiol Cell Physiol; 2016 Jan; 310(2):C142-50. PubMed ID: 26561638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aryl hydrocarbon receptor (AhR) and its endogenous agonist - indoxyl sulfate in chronic kidney disease.
    Kamiński T; Michałowska M; Pawlak D
    Postepy Hig Med Dosw (Online); 2017 Jul; 71(0):624-632. PubMed ID: 28791957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of AhR/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy.
    Lu W; Cheng S; Xu J; Xiao Z; Yu Y; Xie Q; Fang Y; Chen R; Shen B; Xie Y; Ding X
    Toxicol Lett; 2024 May; 396():81-93. PubMed ID: 38670245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated.
    Wakamatsu T; Yamamoto S; Ito T; Sato Y; Matsuo K; Takahashi Y; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
    Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29543732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indoxyl Sulfate Inhibits Osteogenesis in Bone Marrow Mesenchymal Stem Cells through the AhR/Hes1 Pathway.
    Hsieh CW; Chang LH; Wang YH; Li WT; Chang JK; Chen CH; Ho ML
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uremic toxin indoxyl sulfate induces trained immunity via the AhR-dependent arachidonic acid pathway in end-stage renal disease (ESRD).
    Kim HY; Kang YJ; Kim DH; Jang J; Lee SJ; Kim G; Koh HB; Ko YE; Shin HM; Lee H; Yoo TH; Lee WW
    Elife; 2024 Jul; 12():. PubMed ID: 38980302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings.
    Nguyen C; Edgley AJ; Kelly DJ; Kompa AR
    Toxins (Basel); 2022 Jan; 14(2):. PubMed ID: 35202128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
    Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ARHGEF7 (
    Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
    J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury.
    Blattner SM; Hodgin JB; Nishio M; Wylie SA; Saha J; Soofi AA; Vining C; Randolph A; Herbach N; Wanke R; Atkins KB; Gyung Kang H; Henger A; Brakebusch C; Holzman LB; Kretzler M
    Kidney Int; 2013 Nov; 84(5):920-30. PubMed ID: 23677246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
    Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
    J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uremic toxicity of indoxyl sulfate.
    Niwa T
    Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway.
    Gondouin B; Cerini C; Dou L; Sallée M; Duval-Sabatier A; Pletinck A; Calaf R; Lacroix R; Jourde-Chiche N; Poitevin S; Arnaud L; Vanholder R; Brunet P; Dignat-George F; Burtey S
    Kidney Int; 2013 Oct; 84(4):733-44. PubMed ID: 23636172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synaptopodin Is Dispensable for Normal Podocyte Homeostasis but Is Protective in the Context of Acute Podocyte Injury.
    Ning L; Suleiman HY; Miner JH
    J Am Soc Nephrol; 2020 Dec; 31(12):2815-2832. PubMed ID: 32938649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased EGFR expression by activating AhR and Akt.
    Ichisaka Y; Yano S; Nishimura K; Niwa T; Shimizu H
    Biomed Res; 2024; 45(2):57-66. PubMed ID: 38556263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.
    Veron D; Villegas G; Aggarwal PK; Bertuccio C; Jimenez J; Velazquez H; Reidy K; Abrahamson DR; Moeckel G; Kashgarian M; Tufro A
    PLoS One; 2012; 7(7):e40589. PubMed ID: 22808199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRPV1 Hyperfunction Involved in Uremic Toxin Indoxyl Sulfate-Mediated Renal Tubular Damage.
    Lu CL; Liao CH; Lu KC; Ma MC
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD).
    Kim HY; Yoo TH; Hwang Y; Lee GH; Kim B; Jang J; Yu HT; Kim MC; Cho JY; Lee CJ; Kim HC; Park S; Lee WW
    Sci Rep; 2017 Jun; 7(1):3057. PubMed ID: 28596556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Resveratrol on Indoxyl Sulfate-Induced Endothelial Hyperpermeability via Aryl Hydrocarbon Receptor (AHR)/Src-Dependent Pathway.
    Assefa EG; Yan Q; Gezahegn SB; Salissou MTM; He S; Wu N; Zuo X; Ying C
    Oxid Med Cell Longev; 2019; 2019():5847040. PubMed ID: 31885805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.